Francesca Bruce
Senior Reporter at Scrip
Senior Writer at The Pink Sheet
I am a senior writer at the Pink Sheet, all views expressed are my own.
Articles
-
1 week ago |
insights.citeline.com | Francesca Bruce
French Bill Could Improve Clinical Research, But Further Action Is Required France’s simplification bill is a “first step” to improving the country’s clinical research environment, but more could be done to drive decentralized trials and simplify processes, says Leem, the French pharmaceutical industry association. A new bill aimed at cutting red tape for businesses could improve the clinical research environment in France. (Shutterstock)
-
2 weeks ago |
insights.citeline.com | Francesca Bruce
CSL Makes Landmark National-Level Pay-For-Performance Deal In Germany For HemgenixA blanket pricing agreement CSL has formed with German health insurers for the gene therapy, Hemgenix, makes the cost of treatment budget-neutral compared to traditional treatment. CSL Behring's gene therapy Hemgenix is the subject of a first-of-a-kind pay for performance deal with Germany's national insurers. (Shutterstock)
-
2 weeks ago |
insights.citeline.com | Francesca Bruce
New Carbon Monitoring Initiative Could Help Future Proof Clinical ResearchA new European initiative will help trial sponsors better understand whether digitization and decentralized clinical trials of drugs generate less carbon than traditional methods. A new initiative aims to help cut carbon emissions from clinical trials. (Shutterstock)
-
2 weeks ago |
insights.citeline.com | Francesca Bruce
New Medicines Pricing Proposals Would Mean More Uncertainty For Spanish Supply ChainsProposals to reform Spain’s reference pricing system are out of whack with the national pharmaceutical strategy published in December, six industry associations have warned. Spain publishes new decree to improves sustainability of the health care system and improve access to innovative medicines. (Shutterstock)
-
3 weeks ago |
insights.citeline.com | Francesca Bruce
Brazilian Drug Price Increase Rates Hit Eight-Year LowCMED, which sets medicine prices in Brazil, has published the maximum price adjustment index for 2025. Brazil's medicines regulator announces maximum price adjustments permitted in 2025. (Shutterstock)
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 620
- Tweets
- 115
- DMs Open
- No
RT @PharmaPinkSheet: German HTA: Clinical Cancer Registries Could Hold Key To Better Comparative Data For Benefit Assessments https://t.co/…
Lots of interesting sessions today at the DIA Europe 2022 meeting today, looking forward to more tomorrow. @DrugInfoAssn
RT @ScripRegMaureen: Take a look at our free-to-view @PharmaPinkSheet report by @ScripFrancesca on the finer points behind the @EMA_News re…